4.44
-0.015(-0.34%)
Currency In USD
| Previous Close | 4.45 |
| Open | 4.55 |
| Day High | 4.7 |
| Day Low | 4.41 |
| 52-Week High | 7.3 |
| 52-Week Low | 1.26 |
| Volume | 2.31M |
| Average Volume | 4.99M |
| Market Cap | 1B |
| PE | -5.04 |
| EPS | -0.88 |
| Moving Average 50 Days | 3.15 |
| Moving Average 200 Days | 2.72 |
| Change | -0.02 |
If you invested $1000 in Sana Biotechnology, Inc. (SANA) since IPO date, it would be worth $126.35 as of July 30, 2025 at a share price of $4.435. Whereas If you bought $1000 worth of Sana Biotechnology, Inc. (SANA) shares 2 years ago, it would be worth $727.05 as of July 30, 2025 at a share price of $4.435.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
GlobeNewswire Inc.
Jun 23, 2025 2:05 PM GMT
Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression Six-Month Patient Follow-up Results Demonstrate that Sana’s Transplanted Pancreatic Islet Cells Modi
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
GlobeNewswire Inc.
Jun 09, 2025 8:05 PM GMT
Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1 diabetesSEATTLE, June 09, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a compa
Sana Biotechnology to Present at June 2025 Investor Conferences
GlobeNewswire Inc.
May 28, 2025 8:05 PM GMT
SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences